SI-Bone price target raised to $18 from $16 at Truist

Truist raised the firm’s price target on SI-Bone (SIBN) to $18 from $16 and keeps a Buy rating on the shares after its Q3 results. The quarter’s positives far outweighed the negatives, with a Hurricane-impacted revenue miss that was overshadowed by the management’s reiterated 19%-2-% growth trajectory outlook and positive new product launches, the analyst tells investors in a research note.